Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia

Several studies suggest that decreased expression of presynaptic proteins may be characteristic of schizophrenia. We examined one such protein, synapsin, in schizophrenia and bipolar disorder. Samples of hippocampal tissue from controls (n = 13), patients with schizophrenia (n = 16), or bipolar disorder (n = 6), and suicide victims (n = 7) were used. The membrane and cytosolic fractions were analyzed by Western immunoblotting for synapsin using an antibody that detects synapsin Ia, IIa, and IIIa proteins. Synaptophysin was also measured for comparison. Total synapsin was decreased significantly in patients with schizophrenia (P = 0.034) and in bipolar disorder (P = 0.00008) as compared to controls. The synapsin/synaptophysin ratios were decreased in schizophrenia and bipolar disorder, and additionally in suicide victims (P = 0.014). Age, postmortem interval, percentage of protein extracted, and pH of brain were not different between groups. No changes in total synapsin or synaptophysin in the hippocampus were produced by injecting rats with either lithium or haloperidol for 30 days. Reductions in synapsin in both patients with schizophrenia (synapsin IIa and IIIa) and bipolar disorder (synapsin Ia, IIa and IIIa) imply that altered or reduced synaptic function in the hippocampus may be involved in these disorders.

[1]  M. Poulter,et al.  INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA , 1978, The Lancet.

[2]  R. Yolken,et al.  Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. , 1982, Science.

[3]  P. Greengard,et al.  Protein III, a neuron-specific phosphoprotein: variant forms found in human brain. , 1984, Neurobehavioral toxicology and teratology.

[4]  P. Greengard,et al.  Synapsin Ia, Synapsin Ib, Protein IIIa, and Protein IIIb, Four Related Synaptic Vesicle‐Associated Phosphoproteins, Share Regional and Cellular Localization in Rat Brain , 1988, Journal of neurochemistry.

[5]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[6]  P. De Camilli,et al.  Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. , 1989, Science.

[7]  P. Greengard,et al.  An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults. , 1990, Archives of general psychiatry.

[8]  J. Ehrhardt,et al.  Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. , 1990, Archives of general psychiatry.

[9]  James C. Ehrhardt,et al.  Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study , 1992, Biological Psychiatry.

[10]  T. Goldsworthy,et al.  Variation in expression of genes used for normalization of Northern blots after induction of cell proliferation , 1993, Cell proliferation.

[11]  R. Freedman,et al.  Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics , 1993, Biological Psychiatry.

[12]  R. Murray,et al.  Schizophrenia: genetics and the maternal immune response to viral infection. , 1993, American journal of medical genetics.

[13]  W. Fleming,et al.  A quantitative method for assessing protein abundance using enhanced chemiluminescence. , 1993, BioTechniques.

[14]  S. Anderson,et al.  Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. , 1994, Journal of psychiatric research.

[15]  Paul J. Harrison,et al.  Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography , 1995, Neuroscience.

[16]  H. Lachman,et al.  A molecular model for bipolar affective disorder. , 1995, Medical hypotheses.

[17]  Paul Greengard,et al.  Distinct pools of synaptic vesicles in neurotransmitter release , 1995, Nature.

[18]  Paul J. Harrison,et al.  Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia , 1995, Neuroscience.

[19]  R. Murray,et al.  A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). , 1996, American journal of medical genetics.

[20]  J. Deakin,et al.  A two-process theory of schizophrenia: evidence from studies in post-mortem brain. , 1997, Journal of psychiatric research.

[21]  J. Kleinman,et al.  Neuropathology of Suicide , 1997, Annals of the New York Academy of Sciences.

[22]  J. Kleinman,et al.  Abnormal Expression of Cell Recognition Molecules in Schizophrenia , 1998, Experimental Neurology.

[23]  Paul J. Harrison,et al.  Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia , 1998, The Lancet.

[24]  P Falkai,et al.  SNAP-25 deficit and hippocampal connectivity in schizophrenia. , 1998, Cerebral cortex.

[25]  Michael D. Nelson,et al.  Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study , 1998 .

[26]  T. Südhof,et al.  Synapsin III, a Novel Synapsin with an Unusual Regulation by Ca2+ * , 1998, The Journal of Biological Chemistry.

[27]  B. Barraclough,et al.  Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia , 1998, British Journal of Psychiatry.

[28]  Quantification of a neurotrophin receptor from submilligram quantities of brain tissue using western blotting. , 1998, Brain research. Brain research protocols.

[29]  P. Greengard,et al.  A third member of the synapsin gene family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Horrobin.  The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia , 1998, Schizophrenia Research.

[31]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[32]  P. Greengard,et al.  Synapsins as regulators of neurotransmitter release. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[33]  Paul J. Harrison.  The neuropathology of schizophrenia , 2008 .

[34]  P. Greengard,et al.  Regulation of Synaptotagmin I Phosphorylation by Multiple Protein Kinases , 1999, Journal of neurochemistry.

[35]  J. Kleinman,et al.  Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia , 1999, Molecular Psychiatry.

[36]  M. Gavish,et al.  Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. , 1999, Biochimica et biophysica acta.

[37]  H. Coon,et al.  Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. , 1999, American journal of medical genetics.

[38]  Paul J. Harrison,et al.  Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections , 1999, Neuroscience.

[39]  Paul J. Harrison,et al.  Synaptophysin gene expression in schizophrenia , 2000, British Journal of Psychiatry.

[40]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[41]  A. Czernik,et al.  Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique , 2001, Neuroscience Letters.

[42]  E. Torrey,et al.  Surviving Schizophrenia: A Manual for Families, Consumers, and Providers , 2001 .